Clinical Trial Update: Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial completed evaluating nadroparin in patients with lung, pancreatic, or prostate cancer, focusing on venous thrombosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Pancreatic Cancer
• Prostate Cancer
• Venous Thromboembolism

Drugs mentioned

• Nadroparin (nadroparin sodium)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Thrombosis, Venous | Phase 3 | Status: COMPLETED